IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CYAB

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q1 2025Q4 2024Q4 2023
Cash & Equivalents0.793.120.290.690.930.53
Accounts Receivable0.570.220.27--0.11--
Total Current Assets1.983.770.74--1.25--
Property, Plant & Equipment0.140.140.15--0.14--
Total Non-current Assets0.650.760.72--0.69--
Total Assets2.634.531.46--1.95--
Accounts Payable2.022.480.01--1.08--
Short-term Debt2.002.240.20------
Total Current Liabilities13.8516.360.21--18.19--
Long-term Debt--------0.20--
Total Non-current Liabilities0.780.210.75--2.40--
Total Liabilities14.6316.5826.23--20.59--
Retained Earnings(61.58)(58.14)(47.37)--(34.55)--
Total Stockholder Equity(12.00)(12.05)(40.04)(32.34)(30.42)(16.39)
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q2 2025Q1 2025Q1 2024
Total Revenue1.851.421.331.26--
Cost of Revenue0.300.190.210.20--
Gross Profit1.551.221.121.06--
Research & Development2.065.511.841.85--
Selling, General & Admin1.316.281.241.52--
Total Operating Expenses4.6713.054.545.10--
Operating Income(3.12)(11.82)(3.42)(4.04)--
Pretax Income(3.37)(10.77)(2.43)(3.31)--
Tax Provision0.06--0.02----
Net Income(3.44)(10.77)(2.45)(3.31)(15.61)
Basic EPS(0.26)(3.10)(1.07)(1.47)(21.62)
Diluted EPS(0.26)(3.10)(1.07)(1.47)(21.62)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q1 2025
Operating Cash Flow(2.40)(2.60)(1.27)
Capital Expenditures0.020.010.01
Free Cash Flow*(2.42)(2.60)(1.28)
Investing Cash Flow(0.02)-0.00(0.01)
Financing Cash Flow(0.06)5.621.06
← Scroll for more columns →

* Derived from reported values